# Trustar Capital

> Trustar Capital is a VC fund backing Health Care and Manufacturing. See 9 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Hong Kong, Hong Kong
- Total investments: 9
- Last investment: Mar 2026
- Lead investor: 56%
- Last updated: Aug 2026
- Website: http://www.citiccapital.com/SitePages/private-equity-eng.aspx

Trustar Capital is a VC fund in Hong Kong focused on Health Care and Manufacturing. Trustar Capital invests globally in companies which are capitalizing upon the growth and productive resources of the Chinese economy.

## Contacts

5 contacts available for Trustar Capital. Shizune tracks 1 team members at Trustar Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/trustar-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 33% |
| Manufacturing | 3 | 33% |
| Beauty | 2 | 22% |
| Retail | 1 | 11% |
| Medical | 1 | 11% |

17 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Private Equity | 3 | 33% |
| Secondary Market | 2 | 22% |
| Series A | 1 | 11% |
| Series D | 1 | 11% |
| Post-IPO Debt | 1 | 11% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 3 | 33% |
| Hong Kong | 2 | 22% |
| Singapore | 1 | 11% |
| Switzerland | 1 | 11% |
| United States | 1 | 11% |

6 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Zhang Yichen | Founder Chairman & CEO | 5 | https://shizune.co/investors/profile/zhang-yichen |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Yatsen Holding | Yasten provides high-quality fashion makeup products. | $120M | Post-IPO Debt | Mar 11, 2026 |  |
| Deep Intelligent Pharma | Deep Intelligent Pharma (DIP) is a Singapore-based AI company that helps pharmaceutical and biotech companies run clinical trials faster, cheaper, and with fewer mistakes. Its AI platform automates many slow and manual tasks, such as writing trial documents, designing studies, analyzing data, translating medical content for global regulators, andpreparing regulatory submissions. By using thousands of small AI agents supervised by experts, DIP not only saves time but also helps improve the chance that a clinical trial will succeed. Its technology has already been proven in real cases, including an AI-written protocol approved by Japan’s regulator with no revisions. Today, DIP works with over 1,000 life science companies worldwide, including major names like Bayer, Johnson & Johnson, and Roche. | $60M | Series D | Feb 02, 2026 |  |
| Loscam | China Merchants Loscam is a trusted name for providing pooling and returnable packaging solutions for use in supply chains. Operating in 12 regions throughout the Asia Pacific, Loscam is focused on delivering high-quality, innovative and environmentally sustainable solutions and fit-for-purpose systems and procedures to the local markets. Thisdedication has led Loscam to hold a leading market position in various sectors including manufacturing and retail supply chains.Established in 1942, Loscam operates in Australia, China, Hong Kong, Indonesia, Malaysia, Myanmar, New Zealand, Philippines, Singapore, Taiwan, Thailand, and Vietnam. | $472.2M | Secondary Market | Jun 26, 2025 |  |
| i2Cool | i2Cool is a technology start-up that provides new and long-term solutions for a green, low-carbon society. | $12.8M | Series A | May 09, 2024 |  |
| Intramco | Intramco is a manufacturer of components used in electric vehicle charging. |  | Venture - Series Unknown | Oct 19, 2021 |  |
| Rootnet Technology | Rootnet Technology is the IT system provider in the financial industry with the most comprehensive product offerings and the strongest innovative capabilities. |  | Private Equity | Jun 17, 2021 |  |
| Yifei Group | Yifei Group (or “the Company”) is an online business service provider in the beauty and personal care sector. The Company plays a vital role in the ecosystem, provides complete solutions to beauty and personal care brands, as well as small and medium business owners. The Company’s service includes brand incubation, marketing & promotion, onlineshop operation and channel and fulfillment management, and covers all the major ecommerce and social media platforms. It also provides education and one-stop-shop service for hundreds of thousands of sellers, enabling them to start business and serve their respective consumers in the space. In addition, the Company operates Taomeizhuang (or TMZ) Association, which is one of the most influential operating platforms in the market. |  | Private Equity | Apr 27, 2021 |  |
| MedAlliance | MedAlliance is a privately-owned medical technology company. MedAlliance develops innovative drug-eluting balloons (DEBs) for patients suffering from life-threatening coronary and peripheral arterial disease. | $50M | Private Equity | Mar 17, 2021 |  |
| ScentAir | ScentAir Technologies, Inc. provides commercial scent solutions for hospitality, retail, healthcare, and entertainment industries globally. It offers scents and scent delivery systems, and in-store installation and services. The company’s solutions are used in various applications, such as advertising, gaming/casinos, hotels, retail, amusementparks, fitness centers, medical offices, resorts, apartments, funeral homes, military simulation, special events, assisted living, home builders, restaurants, and tradeshows. It offers its products through a network of distributors. ScentAir Technologies, Inc. was formerly known as Fragrance Technologies. The company was founded in 1994 and is based in Charlotte, North Carolina. ScentAir Technologies, Inc. has operations in Southeast Asia. |  | Secondary Market | Feb 19, 2020 |  |

9 of 9 investments shown.

## Co-investors
- [CDH Investments](https://shizune.co/investors/profile/cdh-investments) — VC Fund, 1 deal together
- [China Prosperity Capital](https://shizune.co/investors/profile/china-prosperity-capital) — VC Fund, 1 deal together
- [CITIC Capital Holdings](https://shizune.co/investors/profile/citic-capital-holdings) — VC Fund, 1 deal together
- [Clearwater Bay Capital](https://shizune.co/investors/profile/clearwater-bay-capital) — VC Fund, 1 deal together
- [FountainVest Partners](https://shizune.co/investors/profile/fountainvest-partners) — VC Fund, 1 deal together
- [Hillhouse Ventures](https://shizune.co/investors/profile/hillhouse-ventures) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Breakthrough Energy Ventures](https://shizune.co/investors/profile/breakthrough-energy-ventures) — VC Fund

### Similar stage
- [Foresight Group](https://shizune.co/investors/profile/foresight-group) — VC Fund
- [YFM Equity Partners](https://shizune.co/investors/profile/yfm-equity-partners) — VC Fund
- [Fondaction](https://shizune.co/investors/profile/fondaction) — VC Fund

### Similar country
- [Alibaba Entrepreneurs Fund](https://shizune.co/investors/profile/alibaba-entrepreneurs-fund) — VC Fund
- [Animoca Brands](https://shizune.co/investors/profile/animoca-brands-corporation) — VC Fund
- [Gobi Partners](https://shizune.co/investors/profile/gobi-partners) — VC Fund

## Featured in investor lists
- [Climate VC Funds in Hong Kong](https://shizune.co/investors/climate-vc-funds-hong-kong)
- [Energy Investors in Hong Kong](https://shizune.co/investors/energy-investors-hong-kong)
- [Energy VC Funds in Hong Kong](https://shizune.co/investors/energy-vc-funds-hong-kong)
- [Sustainability Investors in Hong Kong](https://shizune.co/investors/sustainability-investors-hong-kong)
- [Impact Investors in Hong Kong](https://shizune.co/investors/impact-investors-hong-kong)
- [Impact VC Funds in Hong Kong](https://shizune.co/investors/impact-vc-funds-hong-kong)

## FAQ

### What does Trustar Capital invest in?

Trustar Capital invests primarily in Health Care, Manufacturing and Beauty startups, most often at Private Equity and Secondary Market stage. Most of the 9 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Trustar Capital?

Public channels for Trustar Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Trustar Capital?

The team at Trustar Capital includes Zhang Yichen (Founder Chairman & CEO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co